Boston Commerce Limited (BOSTONBIO) is currently trading at 7.96 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Boston Bio Systems Limited is primarily engaged in trading medical equipment, testing kits, and instruments. Originally founded in 1995, the company started with share broking and trading in shares and derivatives. The company's shift to trading medical goods suggests a strategic realignment towards the healthcare sector. There is no detailed updated information on its current performance or market position, indicating limited available data.

Over the past 52 weeks, Boston Commerce Limited has traded between a low of ₹4.01 and a high of ₹10.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Boston Commerce Limited has a market capitalization of approximately 5.31. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Boston Commerce Limited’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -9.16 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 5.31 Cr, Boston Commerce Limited is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Boston Commerce Limited operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Boston Commerce Limited is -9.16. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Boston Commerce reported a net loss of ₹0.5808 crore for the full year ended March 31, 2026, as per its audited standalone results.